成員介紹 » 副校長

趙坤山 副校長

副校長 趙坤山 教授

副校長 趙坤山 教授

聯絡資訊

 

現職

  • 中國醫藥大學 副校長
  • 中國醫藥大學附設醫院癌症中心院長
  • 中國醫藥大學附設醫院生醫產業籌備處長

 

學歷

年度 學歷
1982 高雄醫學大學 醫學系 醫學士

 

經歷

年度 經歷
2008/5-2015 Professor and Chair, Department of Radiation Oncology, Columbia University College of Physicians and Surgeons
2008/5-2014 Residency Program Director, Radiation Oncology Columbia University College of Physicians and Surgeons
2008/5-2015 Professor and Chief, Division of Radiation Oncology, Weill Cornell College of Medicine
2008/5-2015 Director of Combined Radiation Oncology Program at New York Presbyterian Hospital-Columbia University Medical Center- Weill Cornell College of Medicine
2002/6-2008/4 Director of Image-guided Therapy, Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston TX
1998/7-2002/4 Barnes-Jewish Hospital, Cancer Center Committee, St. Louis, MO
1999/7-2002/4 Washington University Medical Center, Human Studies Committee, Internal Review Board, St.Louis, MO
1998/7-2002/4 Barnes-Jewish Hospital, Associate Director of Residency Training Program, St. Louis, MO
1988/7-2002/4 Barnes-Jewish Hospital, Cancer Center, Education Subcommittee, St. Louis, MO
2001/6-2002/5 President, North America Taiwanese Medical Association, St. Louis, MO
1999/7-2001/4 Chair, Membership Committee, North America Taiwanese Professor Association, St. Louis, MO

 

研究領域

  • 癌症放射治療
  • 癌症分子影像診斷及治療
  • 各項特殊癌症治療技術

 

榮譽

榮譽
Best Doctors in America, 2004-2005, 2005-2006, 2007-2008, 2008-2009, 2009-2010, 2011-2012,2012-2013, 2013-2014.
America’s Top Doctors, Castle Connolly Medical – New Yorker Magazine, 2012, 2013, 2014.
Taiwanese American Citizen League (TACL) and Taiwanese American Professionals (TAP) Life Time Achievement Award, 2012.
Chu H. Chang Distinguished Professor, Columbia University College of Physicians and Surgeons, 2008.
Keynote Speaker of 2014 Second Chinese World Congress of Radiological Sciences, Suzhou, China.
Keynote Speaker of 2009 Asian Pacific Head and Neck Oncology Congress, Taipei, Taiwan, September 18, 2009
Keynote Speaker of 2008 International Symposium on Cancer Nanotechnology and Image-guidedTherapy, Taipei, Taiwan, December 25, 2008
Keynote Speaker of 2006 Taiwan Radiology Society meeting, Kaohsiung, Taiwan, March 26, 2006.
Keynote Speaker of 2006 International Society of Gastroenterology Oncology ICACT/ISGIO meeting, Paris, France, February 1, 2006
Annual Oration in Radiation Oncology, Radiological Society of North America (RSNA) Chicago, Illinois, November 30, 2005.
Keynote Speaker of 8th Japan 3-D CRT Symposium, Ciba, Japan, July 25, 2003.
Richard Evan Memorial Lecture at University of Kansas. February 14, 2003.
ASTRO/ESTRO Travel Award Oct. 1997.
Essay Award - Gilbert H. Fletcher Society, Nineteenth Annual Meeting of the Gilbert H. Fletcher Society, Houston, Texas, April 7-9, 1994.
Essay Award - American Brachytherapy Society, Sixteenth Annual Meeting of the American Brachytherapy Society, Scottsdale, Arizona December 8-11, 1993.
Best Intern of the Year, Chang-Gung Memorial Hospital, 1982
President, Medical Student Association, Kaohsiung Medical School, 1981
Head, Aboriginal Area Medical Service Corporation, Kaohsiung Medical School, 1980

 

著作目錄 [ 2011~2018 ]

SELECTED PUBLICATIONS
  1. Burri RJ, Jain AK, Horowitz DP, Deutsch I, Chao KSC. Adjuvant Radiation Therapy In Older Patients With T2 N0 Bladder Cancer Undergoing Limited Surgical Resection: A SEER Database Analysis. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S448-S448.
  2. Burri RJ, Kessel J, Horowitz DP, Sharma CS, Chao KSC. Impact of Radiation Therapy on Survival in Surgically Managed Stage II and III Esophageal Cancer: A SEER Database Analysis. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S316-S317.
  3. Chao KSC. Imaging-guided radiation therapy for head and neck cancer. Oral Oncology. 2011;47:S8-S8.
  4. Chen YJ, Lin CP, Hsu ML, Shieh HR, Chao NK, Chao KSC. Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner. International Journal of Radiation Oncology Biology Physics. 2011;80(3):851-859.
  5.  Coplowitz SR, Chao KSC, Nori D, Parashar B, Christos PJ, Wernicke AG. Pre-treatment Transforming Growth Factor beta-1 (TGF-beta 1) Levels as an Early Predictive Biomarker of Moderate-to-Severe Radiation Induced Fibrosis (RIF) in Patients Treated with Intracavitary Accelerated Partial Breast Irradiation (IAPBI): Results of a Prospective Study. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S63-S63.
  6. Greenwood EA, Patel P, Sharma N, Coplowitz S, Christos PJ, Parashar B, Dattatreyudu N, Chao KSC, Wernicke AG. Prospective Assessment of Pain as a Sequela in Patients Treated with Intracavitary Brachytherapy Accelerated Partial Breast Irradiation (IBAPBI). International Journal of Radiation Oncology Biology Physics. 2011;81(2):S666-S667.
  7. Ng J, Shuryak I, Xu Y, Shah JN, Deutsch I, Chao KS, Brenner DJ, Burri RJ. Predicted Risk of Secondary Lung Malignancies from Breast Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S246-S246.
  8. Parashar B, Edwards A, Mehta R, Pasmantier M, Wernicke AG, Sabbas A, Kerestez RS, Nori D, Chao KSC. Chemotherapy Significantly Increases the Risk of Radiation Pneumonitis in Radiation Therapy of Advanced Lung Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials. 2011;34(2):160-164.
  9. Parashar B, Wernicke AG, Pavese A, Singh P, Trichter S, Sabbas A, Kutler DI, Kuhel W, Port JL, Lee PC, Nori D, Chao KSC. Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. Brachytherapy. 2011;10(6):508-513.
  10. Patel PS, Yan WS, Trichter S, Sabbas A, Rosenblatt R, Drotman MB, Swistel A, Chao KSC, Nori D, Hayes MK. Seroma is an Expected Consequence and not a Complication of MammoSite Brachytherapy. Breast Journal. 2011;17(5):498-502.
  11. Sharma N, Xiang J, Coplowitz S, Patel P, Parashar B, Nori D, Chao KSC, Wernicke AG. Differential Profiles of Gene Expression in Patients developing Radiation-induced Fibrosis (RIF) after Treatment with High Dose Rate Intracavitary Brachytherapy Accelerated Partial Breast Irradiation (IBAPBI): Results of a Prospective Study. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S66-S66.
  12. Stessin A, Wernicke AG, Parashar B, Nori D, Chao KS. The Effects Of Radiation On Survival And Risk Of Histological Transformation In Patients With Low Grade Follicular Lymphoma: An Analysis Of Data From The Surveillance, Epidemiology, And End Results Registry. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S628-S629.
  13. Wang TJ, Chai Y, Chao KSC, Hei TK. Non-targeted Effects in Breast Tissue after Heavy Ion Radiation. International Journal of Radiation Oncology Biology Physics. 2011;81(2):S710-S710.
  14. Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, Christos PJ, Khan I, Vandris K, Parashar B, Nori D, Chao KSC. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Research and Treatment. 2011;125(3):893-902.
  15. Wernicke AG, Parashar B, Kulidzhanov F, Riley L, Christos PJ, Fischer A, Nori D, Chao KSC. Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast. International Journal of Radiation Oncology Biology Physics. 2011;80(1):39-46.
  16. Zhou L, Chi Y, Chao KSC, Chang J. Feasibility Study of Panoramic Cone Beam Computed Tomography (CBCT). International Journal of Radiation Oncology Biology Physics. 2011;81(2):S825-S825.
  17. Chang JW, Zhou LL, Wang S, Chao KSC. Panoramic cone beam computed tomography. Medical Physics. 2012;39(5):2930-2946.
  18. Chen YJ, Kuo CD, Chen SH, Chen WJ, Huang WC, Chao KSC, Liao HF. Small-Molecule Synthetic Compound Norcantharidin Reverses Multi-Drug Resistance by Regulating Sonic Hedgehog Signaling in Human Breast Cancer Cells. Plos One. 2012;7(5).
  19. Cheng S, Corradetti MN, Horowitz DP, Xanthopoulos E, Lusa A, Chao KSC, Rengan R. Case-control study of prophylactic cranial irradiation in nonmetastatic non-small cell lung cancer. Journal of Clinical Oncology. 2012;30(15).
  20. Coplowitz SR, Chao KS, Nori D, Parashar B, Christos PJ, Wernicke AG. Association of Pain and Pretreatment Transforming Growth Factor Beta-1 (TGF-beta 1) Levels as an Early Predictive Biomarker in Patients Treated With Intracavitary Accelerated Partial Breast Irradiation (IAPBI): Results of a Prospective Study. International Journal of Radiation Oncology Biology Physics. 2012;84(3):S242-S243.
  21. Horowitz DP, Ng J, Shuryak I, Chao KSC, Brenner DJ, Cheng S. Predicting the risk of secondary malignancies associated with stereotactic body radiation therapy. Journal of Clinical Oncology. 2012;30(15).
  22. Jain AK, Shuryak I, Ng J, Chao KS, Brenner DJ, Deutsch I. Predicting the Risk of Secondary Malignancies Associated With Pelvic Nodal Irradiation in the Treatment of Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 2012;84(3):S372-S372.
  23. Jilani OK, Singh P, Wernicke AG, Kutler DI, Kuhel W, Christos P, Nori D, Sabbas A, Chao KSC, Parashar B. Radiation therapy is well tolerated and produces excellent control rates in elderly patients with locally advanced head and neck cancers. Journal of Geriatric Oncology. 2012;3(4):337-343.
  24. Li BQ, Chen M, Nori D, Chao KSC, Chen AM, Chen SL. Adjuvant Radiation Therapy and Survival for Pure Tubular Breast Carcinoma-Experience From the SEER Database. International Journal of Radiation Oncology Biology Physics. 2012;84(1):23-29.
  25. Liao HF, Chen YJ, Chen SH, Chao KS. Sonic Hedgehog Signaling Regulates Multi-drug Resistance and Affects Liposomal Doxorubicin Effect in Human Breast Cancer Cells. European Journal of Cancer. 2012;48:S249-S249.
  26. Liao HF, Su YC, Zheng ZY, Cai CJ, Hou MH, Chao KSC, Chen YJ. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomedicine & Pharmacotherapy. 2012;66(5):378-383.
  27. Liao WWP, Chao KSC, Hei TK, Cheng S. Association of IL17-expressing gamma delta t cells with acute radiation-induced pneumonitis. Journal of Clinical Oncology. 2012;30(15).
  28. Ng J, Burri RJ, Horowitz DP, Cesaretti JA, Kao J, Thompson D, Stephens T, Chao KSC, Brenner DJ, Shuryak I. Secondary rectal malignancy risk reduction with IMRT and rectal balloon placement during radiation therapy. Journal of Clinical Oncology. 2012;30(15).
  29. Ng J, Shuryak I, Xu YG, Chao KSC, Brenner DJ, Burri RJ. Predicting the Risk of Secondary Lung Malignancies Associated With Whole-Breast Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 2012;83(4):1101-1106.
  30. Parashar B, Patel P, Singh P, Monni S, Trichter S, Sabbas A, Wernicke AG, Nori D, Chao KSC. Management of Single Malignant Lung Nodules in Elderly Patients (70 Years or Older) Who are Not Candidates for Lobectomy. American Journal of Clinical Oncology-Cancer Clinical Trials. 2012;35(5):480-485.
  31. Parashar B, Wernicke AG, Rice S, Osborne J, Singh P, Nori D, Vallabhajosula S, Goldsmith S, Chao KSC. Early Assessment of Radiation Response Using a Novel Functional Imaging Modality- 18F Fluorocholine PET (FCH-PET): A Pilot Study. Discovery Medicine. 2012;74:13-20.
  32. Wang YF, Chang CJ, Lin CP, Chang SY, Chu PY, Tai SK, Li WY, Chao KSC, Chen YJ. Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2012;34(11):1556-1561.
  33. Wernicke AG, Chao KSC, Nori D, Parashar B, Yondorf M, Boockvar JA, Pannullo S, Stieg P, Schwartz TH. The cost-effectiveness of surgical resection plus cesium-131 (cs-131) brachytherapy versus stereotactic radiosurgery versus surgery 1 whole brain radiotherapy (wbrt) versus wbrt in the treatment of metastatic brain tumors. Neuro-Oncology. 2012;14:139-139.
  34. Wernicke AG, Osborne J, Vallabhajosula S, Goldsmith S, Nori D, Chao KSC, Parashar B. 18F Fluorocholine PET (FCH-PET) during treatment may serve as a predictive biomarker of early response to radiation (RT)/chemoradiation (CRT): results of a pilot study. Tumor Biology. 2012;33:30-30.
  35. Yan P, Cheeseborough JC, Chao KSC. Automatic shape-based level set segmentation for needle tracking in 3-d trus-guided prostate brachytherapy. Ultrasound in Medicine and Biology. 2012;38(9):1626-1636.
  36. Zhou LL, Chao KSC, Chang J. Fast polyenergetic forward projection for image formation using OpenCL on a heterogeneous parallel computing platform. Medical Physics. 2012;39(11):6745-6756.
  37. Boothe D, Patel SH, Stessin A, Parashar B, Nori D, Wernicke AG. Comparing the rates of urinary tract infections among patients receiving adjuvant pelvic intensity modulated radiation therapy, 3-dimensional conformal radiation therapy, and brachytherapy for newly diagnosed endometrial cancer. Pract Radiat Oncol. 2013;3(4):269-274.
  38. Boothe DL, Coplowitz S, Greenwood E, Barney CL, Christos PJ, Parashar B, Nori D, Chao KSC, Wernicke AG. Transforming Growth Factor beta-1 (TGF-beta 1) Is a Serum Biomarker of Radiation Induced Fibrosis in Patients Treated With Intracavitary Accelerated Partial Breast Irradiation: Preliminary Results of a Prospective Study. International Journal of Radiation Oncology Biology Physics. 2013;87(5):1030-1036.
  39. Cho D, Wang S, Chao KSC, Chang J. Optimizing 3D Conformal Plans for 4 pi Non-Coplanar Converging (4PiNC) Beams Using a Genetic Algorithm. International Journal of Radiation Oncology Biology Physics. 2013;87(2):S756-S756.
  40. Greenwood EA, Coplowitz S, Patel P, Sharma N, Kulidzhanov F, Christos PJ, Fischer A, Parashar B, Nori D, Chao KS, Wernicke AG. Assessment of pain as a sequela in patients treated with intracavitary brachytherapy accelerated partial breast irradiation (IBAPBI): preliminary results of a prospective study. Breast J. 2013;19(6):595-604.
  41.  Hsieh CH, Chao KSC, Liao HF, Chen YJ. Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine. 2013.
  42. Huang YC, Chao KSC, Liao HF, Chen YJ. Targeting Sonic Hedgehog Signaling by Compounds and Derivatives from Natural Products. Evidence-Based Complementary and Alternative Medicine. 2013.
  43. Liao HF, Chao KS, Chen YJ, Chang MS. Complementary and alternative medicine in cancer stem cells. Evid Based Complement Alternat Med. 2013;2013:560274.
  44. Nagar H, Boothe D, Parikh A, Yondorf M, Parashar B, Gupta D, Holcomb K, Caputo T, Chao KSC, Nori D, Wernicke AG. Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer. International Journal of Radiation Oncology Biology Physics. 2013;87(4):665-669.
  45. Shah A, Chao KSC, Ostbye T, Castleberry AW, Pietrobon R, Gloor B, Clary BM, White RR, Worni M. Trends in Racial Disparities in Pancreatic Cancer Surgery. Journal of Gastrointestinal Surgery. 2013;17(11):1897-1906.
  46. Su YC, Li SC, Wu YC, Wang LM, Chao KS, Liao HF. Resveratrol downregulates interleukin-6-stimulated sonic hedgehog signaling in human acute myeloid leukemia. Evid Based Complement Alternat Med. 2013;2013:547430.
  47. Wang TC, Zhang C, Wei Y, Horowitz D, Connolly E, Cheng S, Feng W, Chao KSC, Deutsch I. Comparison of effect of rectal volume delineation methods on dose constraint endpoints in the treatment of prostate cancer with intensity-modulated radiation therapy. J Radiat Oncol. 2013;2(3):303-308.
  48. Wernicke AG, Greenwood EA, Coplowitz S, Parashar B, Kulidzhanov F, Christos PJ, Fischer A, Nori D, Chao KS. Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial breast irradiation: results of a prospective trial. Breast J. 2013;19(3):250-258.
  49. Yan WS, Christos P, Nori D, Chao KSC, Ravi A. Is There a Cause-specific Survival Benefit of Postmastectomy Radiation Therapy in Women Younger Than Age 50 With T3N0 Invasive Breast Cancer? A SEER Database Analysis: Outcomes by Receptor Status/Race/Age Analysis Using the NCI Surveillance, Epidemiology, and End Results (SEER) Database. American Journal of Clinical Oncology-Cancer Clinical Trials. 2013;36(6):552-557.
  50. Arora S, Christos P, Pham A, Desai P, Wernicke AG, Nori D, Chao KS, Parashar B. Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis. J Cancer Res Ther. 2014;10(3):526-530.
  51. Berry SL, Polvorosa C, Cheng SM, Deutsch I, Chao KSC, Wuu CS. Initial Clinical Experience Performing Patient Treatment Verification With an Electronic Portal Imaging Device Transit Dosimeter. International Journal of Radiation Oncology Biology Physics. 2014;88(1):204-209.
  52. Liu SH, Chao KS, Leu YS, Lee JC, Liu CJ, Huang YC, Chang YF, Chen HW, Tsai JT, Chen YJ. Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer. Head Neck. 2014.
  53. Nagar H, Yan W, Christos P, Chao KS, Nori D, Ravi A. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death. Am J Clin Oncol. 2014.
  54. Nagar H, Zhou LL, Biritz B, Sison C, Chang JH, Smith M, Nori D, Chao KSC, Hayes MK. Is There a Tradeoff in Using Modified High Tangent Field Radiation for Treating an Undissected Node-Positive Axilla? Clinical Breast Cancer. 2014;14(2):109-113.
  55. Patel SH, Ma Y, Wernicke AG, Nori D, Chao KSC, Parashar B. Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancer. Lung Cancer. 2014;84(2):156-160.
  56. Peng LC, Milsom J, Garrett K, Nandakumar G, Coplowitz S, Parashar B, Nori D, Chao KSC, Wernicke AG. Surveillance, Epidemiology, and End Results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer. Cancer Epidemiology. 2014;38(1):73-78.
  57. Stessin A, Banu M, Boockvar JA, Parashar B, Wernicke AG, Nori D, Chao KSC. MAP Kinase Signaling Differences between Neural Stem Cells and Glioma Cells Provide a Mechanism for Selective Neuroprotection During Cranial Irradiation. International Journal of Radiation Oncology Biology Physics. 2014;90:S148-S148.
  58. Wang S, Li Z, Chao KS, Chang J. Calibration of a detector array through beam profile reconstruction with error-locking. J Appl Clin Med Phys. 2014;15(6):4591.
  59. Wernicke AG, Varma S, Greenwood EA, Christos PJ, Chao KSC, Liu H, Bander NH, Shin SJ. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. Apmis. 2014;122(6):482-489.
  60. Wernicke AG, Yondorf MZ, Peng LK, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Chao KSC, Christos P, Kovanlikaya I, Pannullo S, Boockvar JA, Stieg PE, Schwartz TH. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases Clinical article. Journal of Neurosurgery. 2014;121(2):338-348.
  61. J. Manzerova, J. Chang, M. Santos Delamerced, Z. Li, D. Nori, M.A. Hayes, M.J. Smith, D.J. Brenner, K. Chao, I. Shuryak, J. Ng, Predicting Potential Radiation-Associated Cardiac Risks for Left-Breast Cancer Patients Treated With Postmastectomy or Breast and Regional Nodal Radiation Therapy. International Journal of Radiation Oncology Biology Physics 2014;90, S266
  62. Nagar H, Boothe D, Ginter PS, Sison C, Vahdat L, Shin S, Smith M, Chao KS, Nori D, Hayes MK. Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy. Clin Breast Cancer. 2015;15(2):128-134.
  63. Ye JC, Yan W, Christos P, Nori D, Chao KS, Ravi A. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study. Clin Breast Cancer. 2015;15(1):54-59.
  64. Singh P, Desai P, Arora S, Pham AH, Wernicke AG, Smith M, Nori D, Clifford Chao KS, Parashar B. Comparison of primary radiation versus robotic surgery plus adjuvant radiation in high-risk prostate cancer: a single center experience. J Cancer Res Ther. 2015 Jan-Mar;11(1):191-4. doi: 10.4103/0973-1482.139601.
  65. Wang TJ, Saad S, Qureshi YH, Jani A, Isaacson SR, Sisti MB, Bruce JN, McKhann GM 2nd, Lesser J, Cheng SK, Clifford Chao KS, Lassman AB. Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience. J Neurooncol. 2015 Apr;122(2):399-408. doi: 10.1007/s11060-015-1728-y. Epub 2015 Feb 17.
  66. Jinxue He, Xi Kang, Yuxin Yin, K. S. Clifford Chao & Wen H. Shen, PTEN regulates DNA replication progression and stalled fork recovery. Nature Commun. 2015; 6:7620
  67. Chih-Yang Huang,Shu-Fen Chiang,Tao-Wei Ke,Tsung-Wei Chen,Yu-Ching Lan,Ying-Shu You,An-Cheng Shiau,William Tzu-Liang Chen, K. S. Clifford Chao, Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy. Cancer Immunology. 2018; , 67(4), 551-56